We are live on
!
Find out more
Mackenzie Financial Portfolio holdings
AUM
$83.3B
1-Year Est. Return
31.19%
This Fund
S&P 500
This Quarter
Est. Return
-13.43%
1 Year Est. Return
+31.19%
3 Year Est. Return
+75.49%
5 Year Est. Return
+99.03%
10 Year Est. Return
+295.58%
AUM
$62.4B
AUM Growth
-$12.1B
(-16%)
Cap. Flow
+$109M
Cap. Flow
% of AUM
0.18%
Top 10 Holdings %
Top 10 Hldgs %
22.29%
Holding
1,589
New
182
Increased
754
Reduced
502
Closed
132
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$282M |
| 2 |
Jacobs Solutions
J
|
+$187M |
| 3 |
Telus
TU
|
+$170M |
| 4 |
Shell
SHEL
|
+$166M |
| 5 |
McDonald's
MCD
|
+$132M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Equifax
EFX
|
+$365M |
| 2 |
Automatic Data Processing
ADP
|
+$296M |
| 3 |
Moody's
MCO
|
+$229M |
| 4 |
Toronto Dominion Bank
TD
|
+$218M |
| 5 |
Cenovus Energy
CVE
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 22.28% |
| 2 | Technology | 16.39% |
| 3 | Industrials | 12.25% |
| 4 | Healthcare | 10.92% |
| 5 | Energy | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ELVT
1401
DELISTED
Elevate Credit, Inc.
ELVT
| $47K | ﹤0.01% |
19,754
+2,354
| +14% | +$6.39K |
|
1402
Planet Labs
PL
$7.12B
| $46K | ﹤0.01% |
+10,619
| New | +$54.8K |
|
|
SLGC
1403
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $46K | ﹤0.01% |
+10,200
| New | +$60.7K |
|
1404
Paysafe
PSFE
$414M
| $45K | ﹤0.01% |
+1,933
| New | +$62.4K |
|
1405
Microvision
MVIS
$85.1M
| $44K | ﹤0.01% |
+11,524
| New | +$41.2K |
|
1406
IRIDEX
IRIX
$15.3M
| $42K | ﹤0.01% |
16,462
+4,418
| +37% | +$15K |
|
1407
Ribbon Communications
RBBN
$375M
| $42K | ﹤0.01% |
+13,870
| New | +$41.9K |
|
|
ILLM
1408
DELISTED
illumin Holdings Inc. Common Shares
ILLM
| $42K | ﹤0.01% |
17,840
-3,643
| -17% | -$9.81K |
|
1409
Aquestive Therapeutics
AQST
$454M
| $39K | ﹤0.01% |
+61,699
| New | +$82.1K |
|
1410
Rigel Pharmaceuticals
RIGL
$672M
| $39K | ﹤0.01% |
3,493
+1,496
| +75% | +$30K |
|
|
LOGC
1411
DELISTED
ContextLogic
LOGC
| $38K | ﹤0.01% |
+796
| New | +$43.1K |
|
1412
MacroGenics
MGNX
$231M
| $37K | ﹤0.01% |
+12,666
| New | +$66.6K |
|
|
PHX
1413
DELISTED
PHX Minerals
PHX
| $37K | ﹤0.01% |
+12,290
| New | +$43.1K |
|
|
NVTA
1414
DELISTED
Invitae Corporation
NVTA
| $34K | ﹤0.01% |
13,948
+2,795
| +25% | +$12.4K |
|
|
BHIL
1415
DELISTED
Benson Hill, Inc.
BHIL
| $32K | ﹤0.01% |
+334
| New | +$39.3K |
|
1416
Blend Labs
BLND
$419M
| $30K | ﹤0.01% |
+12,635
| New | +$47.2K |
|
|
DHC
1417
Diversified Healthcare Trust
DHC
$2.12B
| $30K | ﹤0.01% |
16,557
+3,177
| +24% | +$7.26K |
|
1418
Bionano Genomics
BNGO
$12.3M
| $29K | ﹤0.01% |
35
+7
| +25% | +$7.2K |
|
1419
CytomX Therapeutics
CTMX
$681M
| $29K | ﹤0.01% |
15,639
+2,399
| +18% | +$4.59K |
|
1420
Ocugen
OCGN
$420M
| $29K | ﹤0.01% |
12,909
+2,540
| +24% | +$6.08K |
|
1421
Puma Biotechnology
PBYI
$389M
| $29K | ﹤0.01% |
10,090
-2,074
| -17% | -$5.16K |
|
|
ME
1422
DELISTED
23andMe Holding Co
ME
| $29K | ﹤0.01% |
+589
| New | +$34.1K |
|
1423
Workhorse Group
WKHS
$32.9M
| $28K | ﹤0.01% |
+4
| New | +$37.7K |
|
|
VRAY
1424
DELISTED
ViewRay, Inc.
VRAY
| $28K | ﹤0.01% |
+10,523
| New | +$31.7K |
|
|
HEXO
1425
DELISTED
HEXO Corp. Common Shares
HEXO
| $27K | ﹤0.01% |
9,084
-825
| -8% | -$3.94K |
|
Similar funds
Mackenzie Financial's Q2 2022 Portfolio in Review
As of Q2 2022, Mackenzie Financial held 1,589 positions worth $62.4B, down 16% from $74.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Mackenzie Financial's Q2 2022 filing shows 182 new, 754 increased, 502 reduced and 132 closed positions. Its largest new stake was Shell: 2,958,407 shares worth $155M. The largest sale was Equifax, an estimated $365M.
By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 23% a quarter earlier, followed by Technology and Industrials.
- Mackenzie Financial's largest Q2 2022 buy was Shell: 2,958,407 shares worth $155M.
- Mackenzie Financial added most to Linde in Q2 2022, an estimated $282M increase.
- Mackenzie Financial's biggest Q2 2022 reduction was Equifax, cutting an estimated $365M.
- Mackenzie Financial fully exited Vertiv in Q2 2022, selling an estimated $27.3M.
- Mackenzie Financial's ten largest holdings make up 22% of its $62.4B portfolio in Q2 2022.
- Mackenzie Financial opened 182 new positions and closed 132 in Q2 2022.
- Mackenzie Financial's portfolio value fell 16% quarter-over-quarter to $62.4B.
Based on Mackenzie Financial's 13F filing for Q2 2022, filed 10 Aug 2022.